Senechal, Isabelle
Andres, Maria Sol
Tong, Jieli
Perone, Ylenia
Ramalingam, Sivatharshini
Nazir, Muhummad Sohaib
Rosen, Stuart D
Turner, Nicholas
Ring, Alistair
Lyon, Alexander R
Article History
Received: 10 December 2023
Accepted: 25 February 2024
First Online: 8 March 2024
Declarations
:
: the ethics approval was not needed for this study as it is a retrospective and an observational study. We only used data routinely collected in our clinic and no modification to the usual patients’ care was done.
: Not applicable.
: ARL has received speaker, advisory board or consultancy fees and/or research grants from Myocardial Solutions, Pfizer, Novartis, Servier, Astra Zeneca, Amgen, Takeda, Roche, Janssens-Cilag Ltd, Clinigen, Eli Lily, Eisai Ltd, Bristol Myers Squibb, Ferring Pharmaceuticals, Boehringer Ingelheim, iOWNA Health Ltd and Heartfelt Technologies Ltd. AR has received speaker, advisory board or consultancy fees from Roche Products Ltd, Pfizer, Lilly, Novartis, Gilead, Seagen, Astra-Zeneca/Daiichi-Sankyo, ZP therapeutics, and Stemline.